Needham & Company Raises Price Target to $60 Following Conmed's (CNMD) 2Q Miss

July 22, 2015 6:58 AM

Needham & Company reiterated a Buy rating on CONMED (NASDAQ: CNMD), and raised the price target to $60.00 (from $56.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found